MD
Maryland House Bill HB1127

Maryland 2022 Regular Session

Maryland House Bill HB1127 Compare Versions

OldNewDifferences
1- LAWRENCE J. HOGAN, JR., Governor Ch. 296
21
3-– 1 –
4-Chapter 296
5-(House Bill 1127)
62
7-AN ACT concerning
3+EXPLANATION: CAPITALS INDICATE MAT TER ADDED TO EXISTIN G LAW.
4+ [Brackets] indicate matter deleted from existing law.
5+ Underlining indicates amendments to bill.
6+ Strike out indicates matter stricken from the bill by amendment or deleted from the law by
7+amendment.
8+ *hb1127*
89
9-Public Health – State Designated Exchange – Health Data Utility
10+HOUSE BILL 1127
11+J1, J3 2lr2618
12+ CF SB 984
13+By: Delegate Pendergrass
14+Introduced and read first time: February 11, 2022
15+Assigned to: Health and Government Operations
16+Committee Report: Favorable with amendments
17+House action: Adopted
18+Read second time: March 12, 2022
1019
11-FOR the purpose of requiring the State designated exchange to operate as a health data
12-utility for the State for certain purposes; requiring the Maryland Department of
13-Health, dispensers, and certain nursing homes and electronic health networks
14-dispensers to provide certain data to the State designated exchange; requiring
15-dispensers to submit certain prescription information to the State designated
16-exchange; requiring the State designated exchange to establish a certain consumer
17-advisory council; and generally relating to the State designated exchange operating
18-as a health data utility.
20+CHAPTER ______
1921
20-BY adding to
21- Article – Health – General
22-Section 19–145
23- Annotated Code of Maryland
24- (2019 Replacement Volume and 2021 Supplement)
22+AN ACT concerning 1
2523
26- SECTION 1. BE IT ENACTED BY THE GENERAL ASSEMBLY OF MARYLAND,
27-That the Laws of Maryland read as follows:
24+Public Health – State Designated Exchange – Health Data Utility 2
2825
29-Article – Health – General
26+FOR the purpose of requiring the State designated exchange to operate as a health data 3
27+utility for the State for certain purposes; requiring the Maryland Department of 4
28+Health, dispensers, and certain nursing homes and electronic health networks 5
29+dispensers to provide certain data to the State designated exchange; requiring 6
30+dispensers to submit certain prescription information to the State designated 7
31+exchange; requiring the State designated exchange to establish a certain consumer 8
32+advisory council; and generally relating to the State designated exchange operating 9
33+as a health data utility. 10
3034
31-19–145.
35+BY adding to 11
36+ Article – Health – General 12
37+Section 19–145 13
38+ Annotated Code of Maryland 14
39+ (2019 Replacement Volume and 2021 Supplement) 15
3240
33- (A) (1) IN THIS SECTION THE F OLLOWING WORDS HAVE THE MEANINGS
34-INDICATED.
41+ SECTION 1. BE IT ENACTED BY THE GENERAL ASSEMBLY OF MARYLAND, 16
42+That the Laws of Maryland read as follows: 17
3543
36- (2) “DISPENSER” MEANS A PERSON AUTHO RIZED BY LAW TO
37-DISPENSE, AS DEFINED IN § 12–101 OF THE HEALTH OCCUPATIONS ARTICLE, A
38-PRESCRIPTION DRUG TO A PATIENT OR THE PAT IENT’S AGENT IN THE STATE.
44+Article – Health – General 18
3945
40- (3) “NONCONTROLLED PRESCRI PTION DRUG ” MEANS A
41-PRESCRIPTION DRUG , AS DEFINED IN § 21–201 OF THIS TITLE, THAT IS NOT A
42-CONTROLLED DAN GEROUS SUBSTANCE DES IGNATED UNDER TITLE 5, SUBTITLE 4
43-OF THE CRIMINAL LAW ARTICLE.
46+19–145. 19
47+ 2 HOUSE BILL 1127
4448
45- (3) (4) “STATE DESIGNATED EXCH ANGE” HAS THE MEANING
46-STATED IN § 4–302.3 OF THIS ARTICLE.
47- Ch. 296 2022 LAWS OF MARYLAND
4849
49-– 2 –
50- (B) THE STATE DESIGNATED EXCH ANGE SHALL OPERATE A S A HEALTH
51-DATA UTILITY FOR THE STATE.
50+ (A) (1) IN THIS SECTION THE F OLLOWING WORDS HAVE THE MEANINGS 1
51+INDICATED. 2
5252
53- (C) THE PURPOSES OF THE H EALTH DATA UTILITY I NCLUDE THE:
53+ (2) “DISPENSER” MEANS A PERSON AUTHO RIZED BY LAW TO 3
54+DISPENSE, AS DEFINED IN § 12–101 OF THE HEALTH OCCUPATIONS ARTICLE, A 4
55+PRESCRIPTION DRUG TO A PATIENT OR THE PAT IENT’S AGENT IN THE STATE. 5
5456
55- (1) THE COLLECTION , AGGREGATION , AND ANALYSIS OF CLIN ICAL
56-INFORMATION , PUBLIC HEALTH DATA , AND HEALTH ADMINISTR ATIVE AND
57-OPERATIONS DATA TO A SSIST HEALTH CARE AND PUBL IC HEALTH LEADER S THE
58-DEPARTMENT , LOCAL HEALTH DEPARTM ENTS, THE COMMISSION, AND THE
59-HEALTH SERVICES COST REVIEW COMMISSION IN THE EVALUATION OF PUBLIC
60-HEALTH INTERVENTIONS AND HEALTH EQUITY ;
57+ (3) “NONCONTROLLED PRESCRI PTION DRUG ” MEANS A 6
58+PRESCRIPTION DRUG , AS DEFINED IN § 21–201 OF THIS TITLE, THAT IS NOT A 7
59+CONTROLLED DANGEROUS SUBSTANCE DESIGNATED UNDER TITLE 5, SUBTITLE 4 8
60+OF THE CRIMINAL LAW ARTICLE. 9
6161
62- (2) THE COMMUNICATION OF DATA FROM BETWEEN PUBLIC HEALTH
63-OFFICIALS AND HEALTH CARE PROVIDERS TO AD VANCE DISEASE CONTRO L AND
64-HEALTH EQUITY ; AND
62+ (3) (4) “STATE DESIGNATED EXCH ANGE” HAS THE MEANING 10
63+STATED IN § 4–302.3 OF THIS ARTICLE. 11
6564
66- (3) THE ENHANCEMENT AND A CCELERATION OF THE
67-INTEROPERABILITY OF HEALTH INFORMATION T HROUGHOUT THE STATE.
65+ (B) THE STATE DESIGNATED EXCH ANGE SHALL OPERATE A S A HEALTH 12
66+DATA UTILITY FOR THE STATE. 13
6867
69- (D) THE FOLLOWING ENTITIE S DISPENSERS SHALL PROVIDE DATA TO THE
70-STATE DESIGNATED EXCH ANGE:
68+ (C) THE PURPOSES OF THE H EALTH DATA UTILITY I NCLUDE THE: 14
7169
72- (1) THE DEPARTMENT ;
70+ (1) THE COLLECTION , AGGREGATION , AND ANALYSIS OF CLIN ICAL 15
71+INFORMATION , PUBLIC HEALTH DATA , AND HEALTH ADMINISTR ATIVE AND 16
72+OPERATIONS DATA TO A SSIST HEALTH CARE AND PUBL IC HEALTH LE ADERS THE 17
73+DEPARTMENT , LOCAL HEALTH DEPARTM ENTS, THE COMMISSION, AND THE 18
74+HEALTH SERVICES COST REVIEW COMMISSION IN THE EVALUATION OF PUBLIC 19
75+HEALTH INTERVENTIONS AND HEALTH EQUITY ; 20
7376
74- (2) NURSING HOMES REQUIRE D TO PROVIDE DATA UN DER § 4–302.3
75-OF THIS ARTICLE;
77+ (2) THE COMMUNICATION OF DATA FROM BETWEEN PUBLIC HEALTH 21
78+OFFICIALS AND HEA LTH CARE PROVIDERS T O ADVANCE DISEASE CO NTROL AND 22
79+HEALTH EQUITY ; AND 23
7680
77- (3) ELECTRONIC HEALTH NET WORKS REQUIRED TO PR OVIDE DATA
78-UNDER § 4–302.3 OF THIS ARTICLE; AND
81+ (3) THE ENHANCEMENT AND A CCELERATION OF THE 24
82+INTEROPERABILITY OF HEALTH INFORMATION T HROUGHOUT THE STATE. 25
7983
80- (4) DISPENSERS.
84+ (D) THE FOLLOWING ENTITIE S DISPENSERS SHALL PROVIDE DATA T O THE 26
85+STATE DESIGN ATED EXCHANGE : 27
8186
82- (E) (1) THE PURPOSE OF THIS S UBSECTION IS TO:
87+ (1) THE DEPARTMENT ; 28
8388
84- (I) AUTHORIZE INDIVIDUALS AND ORGANIZATIONS IN VOLVED
85-IN THE TREATMENT AND CARE COORDINATION OF PATIENTS TO ACCESS , AS
86-LEGALLY AUTHORIZED , A PATIENT ’S MEDICATION HISTORY , INCLUDING
87-MEDICATIONS PRESCRIBED FOR THE P ATIENT; AND
89+ (2) NURSING HOMES REQUIRE D TO PROVIDE DATA UN DER § 4–302.3 29
90+OF THIS ARTICLE; 30
91+ HOUSE BILL 1127 3
8892
89- (II) ASSIST HEALTH CARE PR OVIDERS, CARE MANAGERS , THE
90-DEPARTMENT , AND PUBLIC HEALTH OFFICI ALS LOCAL HEALTH DEPARTM ENTS TO LAWRENCE J. HOGAN, JR., Governor Ch. 296
9193
92-– 3 –
93-UNDERSTAND AND PROMO TE MATTERS OF HEALTH EQUITY AND TREATMENT
94-EFFICACY.
94+ (3) ELECTRONIC HEALTH NET WORKS REQUIRED TO PR OVIDE DATA 1
95+UNDER § 4–302.3 OF THIS ARTICLE; AND 2
9596
96- (2) AFTER DISPENSING A NONCONTROLLED PRESCRIPTION DRUG , A
97-DISPENSER SHALL SUBM IT PRESCRIPTION INFO RMATION TO THE STATE
98-DESIGNATED EXCHANGE .
97+ (4) DISPENSERS. 3
9998
100- (3) THE PRESCRIPTION INFO RMATION SHALL BE SUB MITTED:
99+ (E) (1) THE PURPOSE OF THIS SUBSECTION I S TO: 4
101100
102- (I) BY ELECTRONIC MEANS ;
101+ (I) AUTHORIZE INDIVIDUALS AND ORGANIZATIONS IN VOLVED 5
102+IN THE TREATMENT AND CARE COORDINATION OF PATIENTS TO ACCESS , AS 6
103+LEGALLY AUTHORIZED , A PATIENT ’S MEDICATION HISTORY , INCLUDING 7
104+MEDICATIONS PRESCRIB ED FOR THE PATIENT ; AND 8
103105
104- (II) WITHOUT UNDULY INCREA SING THE WORKLOAD AN D
105-EXPENSE ON A DISPENS ER;
106+ (II) ASSIST HEALTH CARE PR OVIDERS, CARE MANAGERS , THE 9
107+DEPARTMENT , AND PUBLIC HEALTH OFFICI ALS LOCAL HEALTH DEPARTM ENTS TO 10
108+UNDERSTAND AND PROMO TE MATTERS OF HEALTH EQUITY AND TREATMENT 11
109+EFFICACY. 12
106110
107- (III) IN A MANNER THAT MINIMIZES BURDE N AND DUPLICATION
108-BY BEING AS COMPATIBLE AS POS SIBLE WITH EXISTING FEDERAL STANDARDS FO R
109-DATA SUBMISSION PRAC TICES, INCLUDING TECHNOLOGY SOFTWARE OF
110-DISPENSERS; AND
111+ (2) AFTER DISPENSING A NONCONTROLLED PRESCRIPTION DRUG , A 13
112+DISPENSER SHALL SUBM IT PRESCRIPTION INFO RMATION TO THE STATE 14
113+DESIGNATED EXCHANGE . 15
111114
112- (IV) AS OTHERWISE REQUIRED BY REGULATIONS ADOPT ED BY
113-THE COMMISSION.
115+ (3) THE PRESCRIPTION INFO RMATION SHALL BE SUB MITTED: 16
114116
115- (4) THE STATE DESIGNATED EXCH ANGE MAY NOT IMPOSE ANY FEES
116-OR OTHER ASSESSMENTS ON DISPENSERS TO SUP PORT THE OPERATION O F THE
117-EXCHANGE.
117+ (I) BY ELECTRONIC MEANS ; 17
118118
119- (5) THE STATE DESIGNATED EXCH ANGE SHALL MAKE PRES CRIPTION
120-INFORMATION SUBMITTE D UNDER THIS SUBSECT ION AVAILABLE FOR PU RPOSES OF
121-TREATMENT AND CARE C OORDINATION OF A PAT IENT.
119+ (II) WITHOUT UNDULY INCREA SING THE WORKLOAD AN D 18
120+EXPENSE ON A DISPENS ER; 19
122121
123- (F) THE STATE DESIGNATED EXCH ANGE SHALL MAY PROVIDE DATA , AS
124-ALLOWED BY LAW , TO INDIVIDUALS AND O RGANIZATIONS INVOLVE D IN THE
125-TREATMENT AND CARE COOR DINATION OF PATIENTS AND TO PUBLIC HEALTH
126-OFFICIALS TO SUPPORT PUBLIC HEALTH GOALS , FOR PUBLIC HEALTH PU RPOSES
127-THAT MAY INCLUDE :
122+ (III) IN A MANNER THAT MINIMIZES BURDE N AND DUPLICATION 20
123+BY BEING AS COMPATIBLE AS POS SIBLE WITH EXISTING FEDERAL STANDARDS FO R 21
124+DATA SUBMISSION PRAC TICES, INCLUDING TECHNOLOGY SOFTWARE OF 22
125+DISPENSERS; AND 23
128126
129- (1) UNDERSTANDING AND PRO MOTING THE EQUITABLE
130-AVAILABILITY TO PATI ENTS OF IMPROVING HEALTH EQUI TY THROUG H ACCESS TO
131-PRESCRIPTION MEDICAT IONS, INCLUDING FOR THE TR EATMENT OF INFECTIOU S
132-DISEASE;
127+ (IV) AS OTHERWISE REQUIRED BY REGULATIONS ADOPT ED BY 24
128+THE COMMISSION. 25
133129
134- (2) ASSISTING PROGRAMS LED BY HEALTH CARE PROVIDER S, CARE
135-MANAGERS, AND PUBLIC HEALTH OFFICI ALS IN IDENTIFYING THE DEPARTMENT , Ch. 296 2022 LAWS OF MARYLAND
130+ (4) THE STATE DESIGNATED EXCH ANGE MAY NOT IMPOSE ANY FEES 26
131+OR OTHER ASSESSMENTS ON DISPENSERS TO SUP PORT THE OPERATION O F THE 27
132+EXCHANGE. 28
136133
137-– 4 –
138-LOCAL HEALTH DEPARTM ENTS, THE COMMISSION, AND THE HEALTH SERVICES
139-COST REVIEW COMMISSION TO IDENTIF Y OPPORTUNITIES TO USE TREATMENTS
140-MORE EFFECTIVELY , FOR QUALITY IMPROVEM ENT, INCLUDING FOR STEWAR DSHIP
141-OF ANTIBIOTIC MEDICA TIONS; AND
134+ (5) THE STATE DESIGNATED EXCH ANGE SHALL MAKE PRES CRIPTION 29
135+INFORMATION SUBMITTE D UNDER THIS SUBSECT ION AVAILABLE FOR PURPOS ES OF 30
136+TREATMENT AND CARE C OORDINATION OF A PAT IENT. 31 4 HOUSE BILL 1127
142137
143- (3) ANY ADDITIONAL PATIEN T INTERVENTIONS AND ACTIVITIES,
144-INCLUDING CASE INVES TIGATION CONDUCTING CASE INVES TIGATIONS AND
145-RELATED ACTIVITIES .
146138
147- (G) INFORMATION SUBMITTED TO THE STATE INFORMATION EXC HANGE OR
148-PROVIDED BY THE STATE INFORMATION EXC HANGE UNDER THIS SEC TION SHALL BE
149-SUBMITTED OR PROVIDE D, TO THE EXTENT PRACTICABLE , IN AS NEAR TO REAL T IME
150-AS POSSIBLE.
151139
152- (G) (H) (1) THE COMMISSION, IN CONSULTATION WITH APPROPRIATE
153-STAKEHOLDERS , SHALL ADOPT REGULATI ONS TO CARRY OUT THI S SECTION.
140+ (F) THE STATE DESIGNATED EXCH ANGE SHALL MAY PROVIDE DATA , AS 1
141+ALLOWED BY LAW , TO INDIVIDUALS AND O RGANIZATIONS INVOLVE D IN THE 2
142+TREATMENT AND CARE C OORDINATION OF PATIE NTS AND TO PUB LIC HEALTH 3
143+OFFICIALS TO SUPPORT PUBLIC HEALTH GOALS , FOR PUBLIC HEALTH PU RPOSES 4
144+THAT MAY INCLUDE : 5
154145
155- (2) THE REGULATIONS SHALL TAKE INTO ACCOUNT CO NSUMER
156-PERSPECTIVE A ND INCLUDE:
146+ (1) UNDERSTANDING AND PRO MOTING THE EQUITABLE 6
147+AVAILABILITY TO PATI ENTS OF IMPROVING HEALTH EQUI TY THROUGH ACCESS TO 7
148+PRESCRIPTION MEDICAT IONS, INCLUDING FOR THE TREATMENT OF INF ECTIOUS 8
149+DISEASE; 9
157150
158- (I) THE SPECIFIC DATA REQ UIRED TO BE PROVIDED UNDER
159-SUBSECTION (D) OF THIS SECTION;
151+ (2) ASSISTING PROGRAMS LED BY HEALTH CARE PROVIDER S, CARE 10
152+MANAGERS, AND PUBLIC HEALTH OFFICI ALS IN IDENTIFYING THE DEPARTMENT , 11
153+LOCAL HEALTH DEPARTM ENTS, THE COMMISSION, AND THE HEALTH SERVICES 12
154+COST REVIEW COMMISSION TO IDENTIFY OPPORTUNITIES TO USE TREATMENTS 13
155+MORE EFFECTIVELY , FOR QUALITY IMPROVEM ENT, INCLUDING FOR STEWAR DSHIP 14
156+OF ANTIBIOTIC MEDICA TIONS; AND 15
160157
161- (II) THE SPECIFIC PRESCRIP TION INFORMATION REQ UIRED TO
162-BE SUBMITTED UNDER S UBSECTION (E) OF THIS SECTION;
158+ (3) ANY ADDITIONAL PATIEN T INTERVENTIONS AND ACTIVITIES, 16
159+INCLUDING CASE INVES TIGATION CONDUCTING CASE INVESTIGATIONS AND 17
160+RELATED ACTIVITIES . 18
163161
164- (III) THE TIME FRAME FOR SU BMITTING PRESCRIPTION
165-INFORMATION UNDER SU BSECTION (E) OF THIS SECTION;
162+ (G) INFORMATION SUBMITTED TO THE STATE INFORMATION EXC HANGE OR 19
163+PROVIDED BY THE STATE INFORMATION EXC HANGE UNDER THIS SEC TION SHALL BE 20
164+SUBMITTED OR PROVIDE D, TO THE EXTENT PRACTI CABLE, IN AS NEAR TO REAL T IME 21
165+AS POSSIBLE. 22
166166
167- (IV) THE ELECTRONIC MEANS AND MANNER BY WHICH
168-PRESCRIPTION INFORMA TION IS TO BE SUBMIT TED UNDER SUBSECTION (E) OF THIS
169-SECTION; AND
167+ (G) (H) (1) THE COMMISSION, IN CONSULTATION WITH APPROPRIATE 23
168+STAKEHOLDERS , SHALL ADOPT REGULATI ONS TO CARRY OUT THI S SECTION. 24
170169
171- (V) PRESCRIPTION INFORMAT ION SUBMISSION
172-REQUIREMENTS THAT ALIGN WITH THE DATA SUBMISSION REQU IREMENTS ON
173-DISPENSERS OF MONITO RED PRESCRIPTION DRU GS UNDER TITLE 21, SUBTITLE 2A
174-OF THIS ARTICLE; AND
170+ (2) THE REGULATIONS SHALL TAKE INTO ACCOUNT CO NSUMER 25
171+PERSPECTIVE AND INCLUDE: 26
175172
176- (VI) IDENTIFICATION AND NE CESSARY SUPPRESSION OF
177-INFORMATION RELATED TO PROVIDERS OR MEDI CATIONS THAT ARE DE TERMINED
178-TO HAVE SIGNIFICANT POTENTIAL TO CAUSE H ARM.
179- LAWRENCE J. HOGAN, JR., Governor Ch. 296
173+ (I) THE SPECIFIC DATA REQ UIRED TO BE PROVIDED UNDER 27
174+SUBSECTION (D) OF THIS SECTION; 28
180175
181-– 5 –
182- (I) (1) THE STATE DESIGNATED EXCH ANGE SHALL ESTABLISH A
183-CONSUMER ADVISORY CO UNCIL TO BRING THE P ERSPECTIVES OF INDIV IDUALS AND
184-ORGANIZATIONS WITH A N INTEREST IN PROTEC TING CONSUMERS INTO THE
185-DELIVERY OF SERVICES PROVIDED BY THE STATE DESIGNATED EXCH ANGE.
176+ (II) THE SPECIFIC PRESCRIP TION INFORMATION REQ UIRED TO 29
177+BE SUBMITTED UNDER S UBSECTION (E) OF THIS SECTION; 30
186178
187- (2) IN SELECTING MEMBERS , THE STATE DESIGNATED EXCH ANGE
188-SHALL CONSIDER DIVER SITY OF EXPERIENCE .
179+ (III) THE TIME FRAME FOR SU BMITTING PRESCRIPTIO N 31
180+INFORMATION UNDER SU BSECTION (E) OF THIS SECTION; 32
181+ HOUSE BILL 1127 5
189182
190- (3) THE CONSUMER ADVISORY COUNCIL ESTABLISHED UNDER
191-PARAGRAPH (1) OF THIS SUBSECTION S HALL:
192183
193- (I) CONSIST OF A MINIMUM OF SIX MEMBERS , INCLUDING AT
194-LEAST FOUR CONSUMER REPRESENTATIVES AND TWO STAFF REPRESENTA TIVES,
195-AND MAINTAIN A RATIO OF CONSUMER REPRESEN TATIVES TO NONCONSUM ER
196-REPRESENTATIVES OF A T LEAST TWO TO ONE ;
184+ (IV) THE ELECTRONIC MEANS AND MANNER BY WHICH 1
185+PRESCRIPTION INFORMA TION IS TO BE SUBMIT TED UNDER SUBSECTION (E) OF THIS 2
186+SECTION; AND 3
197187
198- (II) IDENTIFY AND REPORT C ONSUMER PRIVACY CONCERNS TO
199-SENIOR LEADERSHIP OF THE STATE DESIGNATED EXCH ANGE;
188+ (V) PRESCRIPTION INFORMAT ION SUBMISSION 4
189+REQUIREMENTS THAT AL IGN WITH THE DATA SU BMISSION REQUIREMENT S ON 5
190+DISPENSERS OF MONITORED PRESCRIPTION DRUGS U NDER TITLE 21, SUBTITLE 2A 6
191+OF THIS ARTICLE; AND 7
200192
201- (III) ADVISE ON EFFORTS TO EDUCATE CONSUMERS ON DATA
202-EXCHANGE POLICIES , INCLUDING OPTIONS FO R CONSUMERS TO OPT O UT OF
203-DISCLOSURE OF PROTEC TED HEALTH INFORMATI ON;
193+ (VI) IDENTIFICATION AND NE CESSARY SUPPRESSION OF 8
194+INFORMATION RELATED TO PROVIDERS OR MEDI CATIONS THAT ARE DET ERMINED 9
195+TO HAVE SIGNIFICANT POTENTIAL TO CAUSE H ARM. 10
204196
205- (IV) MEET AT LEAST 3 TIMES EACH YEAR ; AND
197+ (I) (1) THE STATE DESIGNATED EXCH ANGE SHALL ESTABLISH A 11
198+CONSUMER ADVISORY CO UNCIL TO BRING THE P ERSPECTIVES OF INDIV IDUALS AND 12
199+ORGANIZATIONS WITH A N INTEREST IN PROTEC TING CONSUMERS INTO THE 13
200+DELIVERY OF SERVICES PROVIDED BY THE STATE DESIGNATED EXCH ANGE. 14
206201
207- (V) ADOPT AND MAINTAIN A CHARTER TO BE POSTED ONLINE
208-THAT INCLUDES THE PU RPOSE, MEMBERS, AND MEETING SCHEDULE OF THE
209-CONSUMER ADVISORY CO UNCIL.
202+ (2) IN SELECTING MEMBERS , THE STATE DESIGNATED EXCH ANGE 15
203+SHALL CONSIDER DIVER SITY OF EXPERIENCE . 16
210204
211- SECTION 2. AND BE IT FURTHER ENACTED, That on or before January 1, 2024,
212-the Maryland Department of Health, the Maryland Health Care Commission, and the State
213-designated exchange shall submit a report to the General Assembly, in accordance with §
214-2–1257 of the State Government Article, that identifies ongoing revenue sources to fund
215-the activities required under § 19–145 of the Health – General Article, as enacted by Section
216-1 of this Act.
205+ (3) THE CONSUMER ADVISORY COUNCIL ESTABLISHED UNDER 17
206+PARAGRAPH (1) OF THIS SUBSECTION S HALL: 18
217207
218- SECTION 3. AND BE IT FURTHER ENACTED, That this Act shall take effect
219-October 1, 2022.
208+ (I) CONSIST OF A MINIMUM OF SIX MEMBERS , INCLUDING AT 19
209+LEAST FOUR CONSUMER REPRES ENTATIVES AND TWO ST AFF REPRESENTATIVES , 20
210+AND MAINTAIN A RATIO OF CONSUMER REPRESEN TATIVES TO NONCONSUM ER 21
211+REPRESENTATIVES OF A T LEAST TWO TO ONE ; 22
220212
221-Approved by the Governor, May 12, 2022.
213+ (II) IDENTIFY AND REPORT C ONSUMER PRIVACY CONC ERNS TO 23
214+SENIOR LEADERSHIP OF THE STATE DESIGNATED EXCHANGE ; 24
215+
216+ (III) ADVISE ON EFFORTS TO EDUCATE CONSUMERS ON DATA 25
217+EXCHANGE POLICIES , INCLUDING OPTIONS FO R CONSUMERS TO OPT O UT OF 26
218+DISCLOSURE OF PROTEC TED HEALTH INFORMATI ON; 27
219+
220+ (IV) MEET AT LEAST 3 TIMES EACH YEAR ; AND 28
221+
222+ (V) ADOPT AND MAINT AIN A CHARTER TO BE POSTED ONLINE 29
223+THAT INCLUDES THE PU RPOSE, MEMBERS, AND MEETING SCHEDULE OF THE 30
224+CONSUMER ADVISORY CO UNCIL. 31
225+
226+ SECTION 2. AND BE IT FURTHER ENACTED, That on or before January 1, 2024, 32
227+the Maryland Department of Health, the Maryland Health Care Commission, and the State 33 6 HOUSE BILL 1127
228+
229+
230+designated exchange shall submit a report to the General Assembly, in accordance with § 1
231+2–1257 of the State Government Article, that identifies ongoing revenue sources to fund 2
232+the activities required under § 19–145 of the Health – General Article, as enacted by Section 3
233+1 of this Act. 4
234+
235+ SECTION 3. AND BE IT FURTHER ENACTED, That this Act shall take effect 5
236+October 1, 2022. 6
237+
238+
239+
240+
241+Approved:
242+________________________________________________________________________________
243+ Governor.
244+________________________________________________________________________________
245+ Speaker of the House of Delegates.
246+________________________________________________________________________________
247+ President of the Senate.